Maximize Returns with AI-Powered ABBV Insights

ABBV Forecast

Bullish Case: AbbVie is projected to benefit from strong sales growth of Skyrizi and Rinvoq, driven by pipeline strength and acquisitions, especially in neuroscience, offsetting losses from Humira's biosimilars.

Bearish Case: Continued legal challenges, biosimilar competition, and disappointing trial results for key drugs, including Emraclidine, threaten AbbVie's financial outlook and investor confidence.

Potential Outcomes:

1. 50% chance: Skyrizi and Rinvoq sales growth continues, significantly boosting revenues.

2. 30% chance: Legal issues adversely impact stock performance.

3. 20% chance: Biosimilar competition accelerates Humira's revenue decline.

Trading Oracle: Given the high implied volatility and market uncertainty, consider a bullish debit spread: buy the $170 call and sell the $175 call. This capitalizes on AbbVie's potential price upturn due to pipeline releases while limiting downside risk.

November 15, 2024

Abbvie Forecast

ABBV Abbvie

Price Forecast
Future Uncertainty

4 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

9 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

20 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

36 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

49 Day Price Forecast + Historical Performance. Video Tutorial: Trade Smarter With Helium's AI Forecasts

See Longer Forecasts

Correlated Assets

Assets that tend to move strongly with ABBV

ICE Intercontinental Exchange (0.83)

JNPR Juniper Networks (0.82)

CURE Direxion Daily Healthcare Bull 3X Shares (0.8)

MHK Mohawk Industries (0.8)

HCA HCA Healthcare (0.78)

Uncorrelated Assets

Assets with little price relationship to ABBV

WY Weyerhaeuser (-0.0)

BUD Anheuser-Busch (0.0)

PENN Penn National Gaming (-0.0)

WBS Webster Financial (0.01)

EVH Evolent Health (0.01)

Anticorrelated Assets

Assets that tend to move strongly against ABBV

PARA Paramount Global (-0.68)

RILY B. Riley Financial (-0.73)

FLNG Flex Lng (-0.75)

CAR Avis Budget (-0.76)

LABD Direxion Daily S&P Biotech Bear 3X Shares (-0.79)

Become a more profitable investor with AI optimized trading strategies

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.